Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh’s National Kala-azar Elimination Programme

Abstract Background Adverse effects of antileishmanial drugs can affect patients’ quality of life and adherence to therapy for visceral leishmaniasis (VL) and post-kala-azar dermal leishmaniasis (PKDL). In Bangladesh, there are 26 treatment centers that manage leishmaniasis cases coming from 100 end...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Md. Sakhawat Hossain, Amresh Kumar, A.F.M Akhtar Hossain, Md. Mahshin, Abhijit Sharma, Md. Akter Hossain, Varun Sharma, Rashidul Haque, A.K.M Shamsuzzaman, Shomik Maruf, Prakash Ghosh, Vivek Ahuja, Dinesh Mondal
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2018-08-01
Serie:	Infectious Diseases of Poverty
Soggetti:	Visceral leishmaniasis Pharmacovigilance Antileishmanial drugs Health system Bangladesh
Accesso online:	http://link.springer.com/article/10.1186/s40249-018-0461-0
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!